Ultrasonography-related Imaging Indication

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2015-02-04
EMA Application withdrawn: Imagify (perflubutane) — Acusphere Ltd
The EMA withdrew the application for Imagify (perflubutane) by Acusphere Ltd for ultrasonography use.